kw.\*:("Virus recombinante")
Results 1 to 25 of 2148
Selection :
Disruption of LANA in Rhesus Rhadinovirus Generates a Highly Lytic Recombinant VirusKWUN WAH WEN; DITTMER, Dirk P; DAMANIA, Blossom et al.Journal of virology. 2009, Vol 83, Num 19, pp 9786-9802, issn 0022-538X, 17 p.Article
Temporal transcription program of recombinant Autographa califomica multiple nucleopolyhedrosis virusSHIH SHENG JIANG; CHANG, I-Shou; HUANG, Lin-Wei et al.Journal of virology. 2006, Vol 80, Num 18, pp 8989-8999, issn 0022-538X, 11 p.Article
Large-scale production of recombinant viruses by use of a large culture vessel with active gassingOKADA, Takashi; NOMOTO, Tatsuya; KUME, Akihiro et al.Human gene therapy. 2005, Vol 16, Num 10, pp 1212-1218, issn 1043-0342, 7 p.Article
Delivery of Cytokines by Recombinant Virus in Early Life Alters the Immune Response to Adult Lung InfectionHARKER, James A; LEE, Debbie C. P; YAMAGUCHI, Yuko et al.Journal of virology. 2010, Vol 84, Num 10, pp 5294-5302, issn 0022-538X, 9 p.Article
Reduced Inflammation and CD4 Loss in Acute SHIV Infection During Oral Pre-Exposure ProphylaxisKERSH, Ellen N; WEI LUO; HENEINE, Walid et al.The Journal of infectious diseases. 2012, Vol 206, Num 5, pp 770-779, issn 0022-1899, 10 p.Article
NeuroBactrus, a Novel, Highly Effective, and Environmentally Friendly Recombinant Baculovirus InsecticideHEE JIN SHIM; JAE YOUNG CHOI; YEON HO JE et al.Applied and environmental microbiology (Print). 2013, Vol 79, Num 1, pp 141-149, issn 0099-2240, 9 p.Article
Bioinformatic Clonality Analysis of Next-Generation Sequencing-Derived Viral Vector Integration SitesARENS, Anne; APPELT, Jens-Uwe; VON KALLE, Christof et al.Human gene therapy. Part B. Methods (Print). 2012, Vol 23, Num 2, pp 111-118, issn 1946-6536, 8 p.Article
Immortalization of human tracheal gland epithelial cells by adenovirus12-SV40 hybrid virusCHOPRA, D. P; TAYLOR, G. W; MATHIEU, P. A et al.In vitro cellular & developmental biology. 1991, Vol 27A, Num 10, pp 763-765, issn 0883-8364Article
Efficient Rescue of Recombinant Lassa Virus Reveals the Influence of S Segment Noncoding Regions on Virus Replication and VirulenceALBARINO, Cesar G; BIRD, Brian H; CHAKRABARTI, Ayan K et al.Journal of virology. 2011, Vol 85, Num 8, pp 4020-4024, issn 0022-538X, 5 p.Article
SWeBLAST : A Sliding Window Web-based BLAST tool for recombinant analysisFOURMENT, Mathieu; GIBBS, Adrian J; GIBBS, Mark J et al.Journal of virological methods. 2008, Vol 152, Num 1-2, pp 98-101, issn 0166-0934, 4 p.Article
Construction of recombinant fowlpox viruses carrying multiple vaccine antigens and immunomodulatory moleculesBOYLE, David B; ANDERSON, Mary-Ann; AMOS, Rachel et al.BioTechniques. 2004, Vol 37, Num 1, pp 104-111, issn 0736-6205, 7 p.Article
Gene therapy meets vaccine developmentCOLLINS, Mary K; CERUNDOLO, Vincenzo.Trends in biotechnology (Regular ed.). 2004, Vol 22, Num 12, pp 623-626, issn 0167-7799, 4 p.Article
Genetically modified filamentous phage as bactericidal agents : A pilot studyHAGENS, S; BLÄSI, U.Letters in applied microbiology. 2003, Vol 37, Num 4, pp 318-323, issn 0266-8254, 6 p.Article
A myxoma virus intergenic transient dominant selection vectorJACKSON, R. J; BULTS, H. G.Journal of general virology. 1992, Vol 73, pp 3241-3245, issn 0022-1317, 12Article
Seroepidemiology of Predominant Norovirus Strains Circulating in Korea by Using Recombinant Virus-Like Particle AntigensSON, Hosun; HYE SOOK JEONG; CHO, Miyoung et al.Foodborne pathogens and disease. 2013, Vol 10, Num 5, pp 461-466, issn 1535-3141, 6 p.Article
Expression of heterologous genes in the Amsacta moorei entomopoxvirusPERERA, Srini C; WONG, Philip; KRELL, Peter J et al.Journal of virological methods. 2010, Vol 165, Num 1, pp 1-8, issn 0166-0934, 8 p.Article
Viral vectors for Cancer gene therapy: Viral dissemination and tumor targetingJIA, William; QUN ZHOU.Current gene therapy. 2005, Vol 5, Num 1, pp 133-142, issn 1566-5232, 10 p.Article
Adenovirus vectors as recombinant viral vaccinesIMLER, J.-L.Vaccine. 1995, Vol 13, Num 13, pp 1143-1151, issn 0264-410XArticle
Reproducible High Yields of Recombinant Adeno-Associated Virus Produced Using Invertebrate Cells in 0.02- to 200-Liter CulturesCECCHINI, Sylvain; VIRAG, Tamas; KOTIN, Robert M et al.Human gene therapy. 2011, Vol 22, Num 8, pp 1021-1030, issn 1043-0342, 10 p.Article
New natural intergenotypic (2/5) recombinant of hepatitis C virusLEGRAND-ABRAVANEL, Florence; CLAUDINON, Julie; NICOT, Florence et al.Journal of virology. 2007, Vol 81, Num 8, pp 4357-4362, issn 0022-538X, 6 p.Article
Downstream processing of viral vectors and vaccinesMORENWEISER, R.Gene therapy (Basingstoke). 2005, Vol 12, pp S103-S110, issn 0969-7128, SUP1Conference Paper
Éléments de galénique virale = Viruses as vectors for gene therapyPAGES, J.-C.Annales de l'Institut Pasteur. Actualités. 1999, Vol 10, Num 3-4, pp 287-299, issn 0924-4204Article
An artificial immune system for making antibodiesMARKS, J. D; WINTER, G.Behring-Institute-Mitteilungen. 1992, Num 91, pp 6-12, issn 0301-0457Article
Pulmonary Vascular Lesions Are Common in SIV- and SHIV-env-Infected MacaquesPATRICIA GEORGE, M; BROWER, Alexandra; NORRIS, Karen A et al.AIDS research and human retroviruses. 2011, Vol 27, Num 2, pp 103-111, issn 0889-2229, 9 p.Article
Topical Nonnucleoside Reverse Transcriptase Inhibitor MC 1220 Partially Prevents Vaginal RT-SHIV Infection of MacaquesSTOLTE-LEEB, Nicole; LODDO, Roberta; STAHL-HENNIG, Christiane et al.AIDS research and human retroviruses. 2011, Vol 27, Num 9, pp 933-943, issn 0889-2229, 11 p.Article